USE OF MONOSIALOGANGLIOSIDE GML OR N-DICHLOR-ACETYL-LYSO-GML TO PREVENT OR REVERSE NEURONAL DEGREES INDUCED BY LONG-TERM TREATMENT WITH L-DOPA IN THERAPY OF MORBUS PARKINSON

摘要

The present invention refers to the use of ganglioside GM1 or the derivative thereof, the N-dichloroacetyl lyso GM1 (LIGA 20) for preventing or reversing neuronal degeneration induced by a long term treatment with L-DOPA in the therapy of Parkinson's disease.